Albert J. Jonker will leave B·R·A·H·M·S Aktiengesellschaft to the 31st of January 2010 on his own wish. As Chief Finance Officer and co-owner he has been shaping B·R·A·H·M·S since 2001 and essentially contributed to the growth of the corporation.

Hennigsdorf / Berlin 24.11.2009. At the invitation of B·R·A·H·M·S over 50 medics and scientists made their way to Berlin on November 6 and 7 to get an update on most recent developments in the field of thyroid cancer.

Thermo Fisher Scientific Inc. (NYSE: TMO) has acquired all of the shares of B·R·A·H·M·S Holding GmbH. The contractual merger resulting from this transaction was announced at the beginning of September. After a four-week inspection, the competent supervisory authorities have now also consented to the agreement.

ProHOSP study demonstrates the value of Procalcitonin marker for lower respiratory tract infections

B·R·A·H·M·S announces the signature of a Share Purchase Agreement (SPA) with Thermo Fisher Scientific Inc. (NYSE: TMO) for 100% of the share capital of B·R·A·H·M·S Holding GmbH in the amount of EUR 330 million (approx. USD 470 million) including debt and other liabilities. The transaction, which is subject to applicable regulatory approvals, is expected to be closed in late September.